What is the best pharmacologic treatment for sickle cell disease pain crises? （開啟新視窗）

Baker M, Hafner JW.

出處‎: Ann Emerg Med 2012;59(6):515-6.

檢索‎: PubMed 22221839

DOI碼‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 （開啟新視窗）

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. （開啟新視窗）

Frei-Jones MJ, Field JJ, DeBaun MR.

出處‎: Pediatr Blood Cancer 2009;53(3):401-5.

檢索‎: PubMed 19422031

DOI碼‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 （開啟新視窗）

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. （開啟新視窗）

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

出處‎: Thromb Haemost 2007;98(2):392-6.

檢索‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 （開啟新視窗）

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. （開啟新視窗）

Okomo U, Meremikwu MM.

出處‎: Cochrane Database Syst Rev 2012;(6):CD005406.

檢索‎: PubMed 22696351

DOI碼‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 （開啟新視窗）

Guidelines for the management of the acute painful crisis in sickle cell disease. （開啟新視窗）

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

出處‎: Br J Haematol 2003;120(5):744-52.

檢索‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 （開啟新視窗）

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. （開啟新視窗）

Ahmad FA, Macias CG, Allen JY.

出處‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

檢索‎: PubMed 21792036

DOI碼‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 （開啟新視窗）

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. （開啟新視窗）

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

出處‎: Hemoglobin 2004;28(2):85-102.

檢索‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 （開啟新視窗）

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. （開啟新視窗）

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

出處‎: Blood 1998;92(9):3082-9.

檢索‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 （開啟新視窗）

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. （開啟新視窗）

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

出處‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

檢索‎: PubMed 20216237

DOI碼‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 （開啟新視窗）

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. （開啟新視窗）

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

出處‎: Haematologica 2013;98(9):1375-82.

檢索‎: PubMed 23645695

DOI碼‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 （開啟新視窗）

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. （開啟新視窗）

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

出處‎: JAMA 2003;289(9):1136-42.

檢索‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 （開啟新視窗）

Predictors of bacteremia in febrile children with sickle cell disease. （開啟新視窗）

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

出處‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

檢索‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 （開啟新視窗）